We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Injectable Collagen Helps Repair Cartilage Defects

By HospiMedica International staff writers
Posted on 11 May 2014
Novel liquid collagen implants for treating damaged cartilage allow cells from surrounding tissues to migrate into the implants. More...


Developed by biotechnology company Amedrix (Esslingen am Neckar, Germany), the ChondroFillerliquid is a dual chamber syringe which applies liquid collagen. The implantation can be done during an arthroscopy; two minutes after the injection into the defect zone, a dimensionally stable gel forms which will is remodeled into the body´s own tissue after a short time. The liquid collagen can treat cartilage defects caused by trauma or degeneration, and it is especially useful for early treatment of smaller defects to prevent serious secondary damages from forming.

ChondroFillerliquid is processed and manufactured in cooperation with the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB; Stuttgart, Germany), where the collagen protein used for the implant is isolated from animal tendons, and then processed in a 215 m2 Good Manufacturing Practice (GMP) unit at the IGB that has been certified by the European Community for developing production processes for medical devices or cell-based tissue-engineered products.

“Our new product is arthroscopically injected as a liquid collagen implant. Once injected, the liquid collagen forms a stable cartilage replacement in minutes,” said Thomas Graeve, CEO of Amedrix. “After injection, cartilage and stem cells from the surrounding tissue migrate into the implant and stimulate the self-healing of the cartilage. Within a short time, the result is a new and resilient cartilage.”

Cartilage structures and functions can be damaged due to a variety of causes, such as a bad fall or traumatic sport-accident, previous knee injuries, or wear and tear over time. Articular cartilage damage in the knee may be found on its own, but it will more often be found in conjunction with injuries to ligaments and menisci. Articular cartilage does not usually regenerate after injury or disease, leading to loss of tissue and formation of a defect.

Related Links:

Amedrix 
Fraunhofer Institute for Interfacial Engineering and Biotechnology



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.